Kasa Bio, L.L.C.
Norcross, GA Doing business as Kasa Bio LLC
- UEI
- CHX9LW14AXB4
- CAGE
- 8E1Y9
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- SAM.gov registration date
- Physical address
- 3949 Holcomb Bridge Rd Ste 301, Norcross, GA 30092, USA
- Website
- kasa-bio.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| A probe-based higher order multiplex technology to expand the capacity of digital PCR systems - abstract absolute… | National Institute of General Medical Sciences | $690,570 | |
| A novel and inexpensive multiplex mirna platform for liver diseases screening - abstract alcohol-associated liver… | National Institute on Alcohol Abuse and Alcoholism | $273,974 | |
| A multiplex platform for quantitative analysis of clinically important gene expression signatures - abstract diffuse… | National Institute of General Medical Sciences | $607,867 |
About Kasa Bio, L.L.C.
Kasa Bio, L.L.C. is a woman-owned small business located in Norcross, Georgia, registered in the System for Award Management (SAM) since August 2019. The company appears to specialize in developing advanced molecular diagnostics and multiplex testing technologies, with a focus on innovative biochemical and genetic analysis platforms. Operating as a for-profit partnership, Kasa Bio has demonstrated expertise in creating high-complexity diagnostic solutions that aim to improve clinical research and molecular testing capabilities across various medical domains.
The company has secured multiple federal grant awards from prestigious agencies including the National Institute of General Medical Sciences and the National Institute on Alcohol Abuse and Alcoholism, focusing on developing advanced molecular diagnostic technologies. Specifically, Kasa Bio has pursued three notable grant-funded projects: a digital PCR technology for detecting gene fusions related to chronic myeloid leukemia, a multiplex microRNA platform for liver disease screening, and a gene expression signature analysis platform for differentiating lymphoma subtypes. Each project involves their proprietary "ZIP-Melt" multiplex probe technology, designed to enable more efficient, cost-effective, and environmentally friendly molecular testing methods. These grants, ranging from $300,000 to $500,000, demonstrate the company's commitment to developing innovative diagnostic technologies that can potentially reduce healthcare costs, improve testing efficiency, and provide more comprehensive molecular analysis capabilities across different medical research and clinical contexts.
Quick answers
What is Kasa Bio, L.L.C.'s UEI?
Kasa Bio, L.L.C.'s Unique Entity ID (UEI) in SAM.gov is CHX9LW14AXB4.
What is Kasa Bio, L.L.C.'s CAGE code?
Kasa Bio, L.L.C.'s CAGE code is 8E1Y9.
Where is Kasa Bio, L.L.C. located?
Kasa Bio, L.L.C.'s physical address in SAM.gov is 3949 Holcomb Bridge Rd Ste 301, Norcross, GA 30092, USA.
Is Kasa Bio, L.L.C. registered in SAM.gov?
Yes. Kasa Bio, L.L.C.'s SAM.gov registration is active through April 15, 2027.
What is Kasa Bio, L.L.C.'s most recent federal award?
Kasa Bio, L.L.C.'s most recent federal grant award is A probe-based higher order multiplex technology to expand the capacity of digital PCR systems - abstract absolute… (R43GM160998), from National Institute of General Medical Sciences, on May 1, 2025.
On GovTribe
See Kasa Bio, L.L.C.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors